Overview

• Under the settlement, UnitedHealth and Amedisys must sell 164 home health and hospice facilities in 19 states representing roughly $528 million in annual revenue.
• Amedisys will pay a $1.1 million civil penalty for miscertified Hart-Scott-Rodino disclosures.
• A court-appointed monitor will oversee the divestiture process and enforce buyer-protection provisions to maintain competition.
• The settlement obliges the companies to divest eight additional locations if initial sales fail to secure regulatory sign-off.
• Following a 60-day public comment period, a federal judge will review the proposed consent decree before the $3.3 billion merger can close.